A PHASE 2/3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC IN ADULT PARTICIPANTS WITH BULLOUS PEMPHIGOID

Registry ID

ARGX-113-2009

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ARGENX BV

Last update

2023-09-14

Conditions

• BULLOUS PEMPHIGOID

View on source registry